Viewing Study NCT06276868

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:41 PM
Ignite Modification Date: 2026-02-07 @ 11:05 PM
Study NCT ID: NCT06276868
Status: RECRUITING
Last Update Posted: 2024-12-17
First Post: 2023-11-14
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Darsilide Combined With AI, Trastuzumab and Patuzumab in the Neoadjuvant Treatment of HR+/HER2+ Breast Cancer
Sponsor: Henan Cancer Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
None HER2-positive Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HER2-positive Breast Cancer View
None pathologic complete response View
None Dalcelli View
None objective response rate View
None Disease-free survival View